Janette asked: “Why do never-smokers get lung cancer?”
“It is a question that often comes up in the clinic,” says Dr Mariam Jamal-Hanjani, an oncologist and clinical researcher specialising in lung cancer at University College London. “And it is one that researchers have been asking for decades.”
The link between smoking and lung cancer has been known for almost 70 years. It’s the biggest cause of lung cancer in the UK, with around 7 in 10 lung cancers caused by smoking cigarettes. But there’s also a group of people who develop lung cancer and have never lit a cigarette.
Oncimmune (LON:ONC) is a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. Oncimmune is changing how clinicians, researchers and patients view, diagnose and treat cancer. Our technology detects evidence of the body’s natural response to cancer, enabling detection 4 years or more before standard clinical diagnosis. Our tests facilitate clinical decision-making and are complementary to diagnostic technologies, making them valuable additions to established and new care pathways. We partner with leading developers and distributors to make our technology available globally.
